National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Malaria
 Understanding Malaria
 Malaria Research
  NIAID's Role
  Basic Biology
  Prevention and Control
  Partnerships and Research Capacity
  NIAID Labs
  Services for Researchers
  Malaria Vaccine Development Branch


Malaria

Services for Researchers

Parasite Biology and Vector Biology

Malaria Research and Reference Reagent Resource Center (MR4) (Non-government)

Genomics

Bioinformatics Resource Centers

Microbial Genome Sequencing Centers

Pathogen Functional Genomics Resource Center

Proteomics Research Centers

Immunology

NIH Tetramer Facility (Non-government)

Immune Epitope Database and Analysis Resource (Non-government)

Taconic Emerging Mouse Models Program (Non-government)

NIH Nonhuman Primate Reagent Resource (Non-government)

NIH AIDS Research and Reference Reagent Program (Non-government)

Vaccine Development

Malaria Vaccine Production and Support Services Contract (Request for Proposal)

Vaccine and Treatment Evaluation Units

Drug Development

Services for the Pre-Clinical Development of Therapeutics Agents (Request for Proposal)

HIV/AIDS Clinical Trial Networks

back to top

See Also

Once Effective Anti-Malaria Drug Shows Promise Again in Africa

Related Links

Global Research, Africa

Status of NIAID Adenovirus-based Vaccine Studies

Laboratory of Malaria and Vector Research (LMVR)

E-mail Icon E-mail this page
Print Icon Print this page

See Also

Once Effective Anti-Malaria Drug Shows Promise Again in Africa

Related Links

Global Research, Africa

Status of NIAID Adenovirus-based Vaccine Studies

Laboratory of Malaria and Vector Research (LMVR)